A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery. Contraception. 2022 Feb 18:9788. doi: 10.1016/j.contraception.2022.01.019. Epub ahead of print.